Device brand name · Staple implantable
Egia 45 Articulating Med/Thick Sulu: medical device reports filed with FDA
152 reports name it, 2011–2017. Manufacturer given most often on reports: Covidien Formerly US Surgical A Divison. Product code GDW.
- 152
- device reports naming the brand
- 0% of all MAUDE reports · about 10 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 56.6%
- classified as malfunction
- 80.3% across the product code
- 0.7%
- classified as death, as reported
- 1 reports · not verified by FDA
152 medical device reports received by FDA name the brand "Egia 45 Articulating Med/Thick Sulu" (staple implantable); the manufacturer given most often on reports is Covidien Formerly US Surgical A Divison; received from April 2011 to March 2017. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (56.6%), injury (41.4%) and death (0.7%); across all staple, implantable reports (product code GDW) death is recorded in 0.6% and malfunction in 80.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure to cycle (22.4%), failure to fire (19.7%) and failure to form staple (10.5%). The patient problems coded most often are tissue damage, hemorrhage/blood loss/bleeding and injury. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Egia 45 Articulating Med/Thick Sulu was received in the five years to August 2026; the latest was received in March 2017.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 170,752 reports carrying product code GDW. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure to cycle | 34 | 22.4% | 0.2% |
| Failure to fire | 30 | 19.7% | 30% |
| Failure to form staple | 16 | 10.5% | 20.5% |
| Difficult to open or close | 10 | 6.6% | 9.7% |
| Device operates differently than expectedthe device behaved unexpectedly | 9 | 5.9% | 2.3% |
| Misfire | 9 | 5.9% | 9.1% |
| Breakthe device broke | 8 | 5.3% | 4.9% |
| Insufficient device problem information | 5 | 3.3% | 2.9% |
| Detachment of device component | 4 | 2.6% | 1.2% |
| Difficult to removethe device was hard to remove | 4 | 2.6% | 1.7% |
| Mechanics altered | 4 | 2.6% | 1.4% |
| Failure to advance | 3 | 2% | 0.4% |
| Failure to cut | 3 | 2% | 2.4% |
| Component falling | 2 | 1.3% | 0.5% |
| Device inoperablethe device could not be used | 2 | 1.3% | 0.5% |
| Device stops intermittentlythe device stopped now and then | 2 | 1.3% | 0.1% |
| Difficult to advance | 2 | 1.3% | 0.1% |
| Entrapment of device | 2 | 1.3% | 3.2% |
| Material deformation | 2 | 1.3% | 0.2% |
| Noise, audible | 2 | 1.3% | 2.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Tissue damage | 21 | 13.8% |
| Hemorrhage/blood loss/bleeding | 12 | 7.9% |
| Injurya physical injury | 7 | 4.6% |
| Failure to anastomose | 6 | 3.9% |
| Blood loss | 3 | 2% |
| Fistula | 2 | 1.3% |
| Fluid discharge | 2 | 1.3% |
| No patient involvement | 2 | 1.3% |
| Post operative wound infection | 2 | 1.3% |
| Deaththe patient died; cause not stated by this term | 1 | 0.7% |
| Fever | 1 | 0.7% |
| Hematomaa collection of blood under the skin or in tissue | 1 | 0.7% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Egia 45 Articulating Med/Thick Sulu | Product code GDW | All MAUDE reports |
|---|---|---|---|
| Reports | 152 | 170,752 | 26,136,888 |
| Share of that pool | — | 0.1% | 0% |
| Classified as death, per 1,000 reports | 7 | 6 | 9 |
| Classified as injury | 41.4% | 18.7% | 36.2% |
| Classified as malfunction | 56.6% | 80.3% | 62.3% |
| Filed by the manufacturer | 100% | 97% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code GDW
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Endo GIA | 30,619 | 2,086 | 0.3% |
| Endo GIA Ultra | 17,281 | 1,116 | 0.1% |
| Signia | 9,434 | 1,130 | 0.1% |
| Tri-Staple 2.0 | 5,267 | 661 | 0.3% |
| Gia | 4,899 | 404 | 0.9% |
| Eea | 4,922 | 542 | 0.8% |
| Powered 60 Echelon + 340mm Shaft | 3,237 | 224 | 0.4% |
| Ets Flex Articng Lnr Cutr 45mm | 2,512 | 79 | 0.3% |
| Unknown Endo GIA SULU | 2,408 | 205 | 1.9% |
| SureForm | 2,927 | 654 | 1.2% |
| Contour Curved Cutter Stapler | 1,961 | 11 | 0.3% |
| Ils 29mm Curved | 1,945 | 48 | 0.9% |
| Powered 60 Echelon + 440mm Shaft | 1,775 | 49 | 0.4% |
| Echelon Flex Powered Vascular Stapler With Advanced Placement Tip | 1,770 | 180 | 1.6% |
| 75mm Selectable New Tlc | 1,603 | 57 | 1.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Egia 45 Articulating Med/Thick Sulu reports
How many FDA reports name Egia 45 Articulating Med/Thick Sulu?
152 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (56.6%), injury (41.4%) and death (0.7%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure to cycle (22.4%), failure to fire (19.7%), failure to form staple (10.5%), difficult to open or close (6.6%) and device operates differently than expected (5.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Egia 45 Articulating Med/Thick Sulu was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.